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Dear Editors,
Major depressive disorder in late life is a very heterogeneous 
illness, and the neurobiological bases of this condition remain 
unclear.1 Recent investigation has hypothesized that the 
apolipoprotein E epsilon4 (ApoE4) allele could be associated 
with late-life depression.2 
ApoE4 is a well-established risk factor for late-onset 
Alzheimer’s disease. Varying degrees of cognitive dysfunction 
have been described in non-demented individuals with one 
or two epsilon4 alleles, leading to suggestions that the gene 
could play a role in cognitive impairment.3 This knowledge has 
generated interest in the infl uence of ApoE variants on cognition 
in different psychiatric conditions. Thus, we have performed a 
study in order to investigate the role of the ApoE4 allele in the 
cognition of patients with major depressive disorder according 
to the criteria established by the Diagnostic and Statistical 
Manual of Mental Disorders, 4th edition (DSM-IV).
Thirteen elderly patients older than 60 years [nine women 
(69.2%) and four men (30.8%)], all of them with a diagnosis 
of major depressive disorder according to DSM-IV criteria, 
were included in the study. Blood samples of all subjects were 
collected for genetic investigation. Patients were divided into two 
groups, according to the presence or absence of the ApoE4 allele 
(ApoE4 and non-ApoE4 groups). Genotyping was performed 
by two investigators according to Hixson & Vernier,4 using the 
HhaI restriction enzyme. In order to avoid errors, genotyping 
was repeated when the results of both trained investigators were 
not the same. All patients provided written informed consent, 
and the study protocol was approved by the Research Ethics 
Committee at Hospital das Clínicas da Faculdade de Medicina 
da Universidade de São Paulo, São Paulo, Brazil. 
Cognitive impairment was assessed by submitting the 
patients to a neuropsychological evaluation which included 
the cognitive test of the Cambridge Examination for Mental 
Disorders of the Elderly (CAMCOG) and the Mini-Mental State 
Examination (MMSE). The presence of depressive symptoms 
was assessed using the Montgomery-Åsberg Depression Rating 
Scale (MADRS). Signifi cance was set at p = 0.05. 
Statistical analyses showed an association between 
presence of ApoE4 and cognitive impairment measured 
by CAMCOG (Table 1). There was a trend of association 
between cognitive impairment measured by MMSE and the 
investigated allele (Table 1). Age and educational level did not 
differ after the two groups were compared by an independent 
t test (age, p = 0.975; years at school, p = 0.137). There was 
no difference between the groups in terms of depressive 
symptoms investigated using MADRS (p = 0.124). 
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Table 1 – Cognitive performance and ApoE4 distribution
  ApoE4 Non-ApoE4 p
CAMCOG 68.88±18.43 90.20±11.52 0.026*
MMSE 21.25±5.01 26.60±3.85 0.055*
Results presented as means ± standard deviation. * Student t-test
Depressed elderly
According to our fi ndings, the presence of the ApoE4 
allele was associated with greater cognitive impairment in older 
patients with major depressive disorder. We also found that 
cognitive impairment was not infl uenced by age, educational 
level, or severity of depressive symptoms. In a recent report, 
ApoE4 was found to be an independent contributor to cognitive 
decline in a community-based sample.5 Thus, ApoE4 may act 
disrupting neurological functioning, which in turn may reduce 
the individuals’ cognitive reserve capacity.5 Such results support 
the hypothesis that the presence of ApoE4 may be associated 
with cognitive impairment in elderly depressive patients.
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